How to Value Orphan Drugs? A Review of European Value Assessment Frameworks
Background: Decision-makers have implemented a variety of value assessment frameworks (VAFs) for orphan drugs in European jurisdictions, which has contributed to variations in access for rare disease patients. This review provides an overview of the strengths and limitations of VAFs for the reimburs...
Saved in:
Main Authors: | Alessandra Blonda (Author), Yvonne Denier (Author), Isabelle Huys (Author), Steven Simoens (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries
by: Alessandra Blonda, et al.
Published: (2022) -
Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries
by: Alessandra Blonda, et al.
Published: (2022) -
Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review
by: Khadidja Abdallah, et al.
Published: (2021) -
How to assess the value of medicines?
by: Steven Simoens
Published: (2010) -
Emerging Insights into European Markets of Biologics, Including Biosimilars
by: Steven Simoens, et al.
Published: (2022)